Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil

Appl Health Econ Health Policy. 2017 Apr;15(2):163-172. doi: 10.1007/s40258-016-0290-x.

Abstract

Background: Little is known about the quality and quantity of cost-utility analyses (CUAs) in Brazil.

Objective: The objective of this study was to provide a systematic review of published CUAs of healthcare technologies in Brazil.

Methods: We performed a systematic review of economic evaluations studies published in MEDLINE, EMBASE, LILACS (Latin American and Caribbean Health Sciences Literature), SciELO (Scientific Electronic Library Online), NHS EED (National Health Service Economic Evaluation Database), HTA (Health Technology Assessment) Database, Web of Science, Scopus, Bireme (Biblioteca Regional de Medicina), BVS ECOS (Health Economics database of the Brazilian Virtual Library of Health), and SISREBRATS (Sistema de Informação da Rede Brasileira de Avaliação de Tecnologias em Saúde [Brazilian Network for the Evaluation of Health Technologies]) from 1980 to 2013. Articles were included if they were CUAs according to the classification devised by Drummond et al. Two independent reviewers screened articles for relevance and carried out data extraction. Disagreements were resolved through discussion or through consultation with a third reviewer. We performed a qualitative narrative synthesis.

Results: Of the 535 health economic evaluations (HEEs) relating to Brazil, only 40 were CUAs and therefore included in the analysis. Most studies adhered to methodological guidelines for quality of reporting and 77.5% used quality-adjusted life-years (QALYs) as the health outcome. Of these studies, 51.6% did not report the population used to elicit preferences for outcomes and 45.2% used a specific population such as expert opinion. The preference elicitation method was not reported in 58.1% of these studies. The majority (80.6%) of studies did not report the instrument used to derive health state valuations and no publication reported whether tariffs (or preference weights) were national or international. No study mentioned the methodology used to estimate QALYs.

Conclusions: Many published Brazilian cost-utility studies adhere to key recommended general methods for HEE; however, the use of QALY calculations is far from being the current international standard. Development of health preferences research can contribute to quality improvement of health technology assessment reports in Brazil.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Brazil
  • Cost-Benefit Analysis* / methods
  • Cost-Benefit Analysis* / standards
  • Cost-Benefit Analysis* / statistics & numerical data
  • Humans
  • Quality-Adjusted Life Years
  • Technology Assessment, Biomedical / methods
  • Technology Assessment, Biomedical / standards
  • Technology Assessment, Biomedical / statistics & numerical data
  • Treatment Outcome